Explore the Effect of Diet Intervention on Lipid Metabolism and Body Mass Index Among the Patients With Metabolic Syndrome
- Conditions
- Metabolic Syndrome
- Registration Number
- NCT04475822
- Brief Summary
The prevalence of metabolic syndrome (MetS) is increasing all over the world, which is largely related to the increasing obesity population and the current inactive lifestyle of human beings. It is a common problem facing public health and clinical practice.Metabolic syndrome is an accumulation of biologically metabolic risk factors related to cardiovascular disease and diabetes, including glucose metabolism disorders, hypertension, dyslipidemia, and obesity (especially central obesity).Researchers believe that the common pathological basis of these manifestations is insulin resistance, which is generally considered to be a reduction in the biological effects of insulin compared with the normal biological effects of expected biological phenomena.Nowadays, there are more and more studies on insulin resistance in the world. We have known that age, poor living and eating habits, high blood fat, high blood sugar and stress all lead to insulin resistance.
The researchers hope to reduce weight, reduce body fat rate, improve body fat distribution and insulin resistance, reverse abnormal metabolic indicators, and ultimately reduce the incidence of chronic diseases in patients with metabolic syndrome through the intervention of lifestyle and diet habits in the early stage of the disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 169
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method weight Three months after the intervention kg
body fat Three months after the intervention
- Secondary Outcome Measures
Name Time Method blood pressure Three months after the intervention mmHg
blood glucose Three months after the intervention mmol/L
uric acid Three months after the intervention µmol/L
blood lipid Three months after the intervention mmol/L
Trial Locations
- Locations (1)
First Affiliated Hospital of Xi an Jiaotong University
🇨🇳Xi'an, Shaanxi, China
First Affiliated Hospital of Xi an Jiaotong University🇨🇳Xi'an, Shaanxi, China